MetaTrader
  • Markets
  • Charts & Ideas
  • Algo
  • News
  • Store
  • Brokers
  • Download
  • Economic Calendar
  • Trading Signals
  • WebTerminal
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Iterum Therapeutics plc Ordinary Share

ITRM

#3825
Iterum Therapeutics plc Ordinary Share
0.26
+13.04%
Sector:
Base:
Profit Currency:
Daily Range
0.26
0.26
Year Range
0.20
1.51
Daily Change
+13.04%
Monthly Change
-21.21%
6 month change
-63.38%
Year Change
-80.60%
Previous Close
0.23
Open
0.26
Bid
Ask
Low
0.26
High
0.26
Volume
2
  1. Markets
  2. US Stock Market
  3. Healthcare
  4. ITRM
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
Value 20202021202220232024 TTM

News

Investing Investing
ITRM
2026.02.13
Iterum Therapeutics expands Medicare Part D access for ORLYNVAH
Investing Investing
ITRM
2025.12.23
Iterum Therapeutics expands market access for ORLYNVAH antibiotic
Investing Investing
ITRM
2025.12.17
Iterum Therapeutics secures major PBM agreement for antibiotic
Investing Investing
ITRM
2025.12.12
Iterum Therapeutics receives Nasdaq notice on listing compliance
Investing Investing
ITRM
2025.12.05
Iterum Therapeutics expands reimbursement coverage for ORLYNVAH
Investing Investing
ITRM
2025.11.24
Iterum’s antibiotic ORLYNVAH now available through McKesson
Investing Investing
ITRM
2025.11.20
Iterum Therapeutics director Dunne buys $2,191 in shares
Seeking Alpha Seeking Alpha
ITRM
2025.11.14
Iterum Therapeutics plc (ITRM) Q3 2025 Earnings Call Transcript
Investing Investing
SR-PA FSI TOMZ SRRK ITRM
2025.11.13
Allianz, Richemont, Swiss Re, and more set to report earnings Friday
Benzinga Benzinga
B PLUG ASTS BBAI RGTI
2025.11.10
Top Stocks With Earnings This Week: Plug, Oklo, Circle And More - Rigetti Computing (NASDAQ:RGTI)
Investing Investing
ITRM
2025.10.16
Iterum Therapeutics launches $20 million at-the-market share offering
Investing Investing
ITRM
2025.09.19
Iterum Therapeutics launches antibiotic ORLYNVAH in targeted U.S. markets

Markets

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Charts & Ideas

  • Trading Ideas
  • Education Ideas
  • Charts

MQL5 Community

  • Market
  • Signals
  • Forum
  • Articles
  • CodeBase

News

  • US Stock Market
  • Currencies
  • Cryptocurrencies
  • Metals
  • Commodities

Brokers

  • All Brokers
  • Forex
  • Stock
  • Metals
MetaTrader 5
MQL5 Channels
Economic Calendar
Disclaimer and Risk Disclosure Terms of Use Contacts and Requests Legal
Copyright 2000-2026, MetaQuotes Ltd